Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

Left unaddressed, non-alcoholic fatty liver disease (NAFLD) will continue to have substantial
health, economic and social implications. To address the challenge, a paradigm shift is …

Over 1.5 million preventable new hepatitis B infections continue to occur each year and
there are an estimated 296 million people living with chronic hepatitis B infection worldwide …

Summary Background In 2016, the World Health Assembly adopted the resolution to
eliminate viral hepatitis by 2030. This study aims to provide an overview of the burdens of …

Hepatocellular carcinoma (HCC) is a leading cause of global cancer death. Major etiologies
of HCC relate to chronic viral infections as well as metabolic conditions. The survival rate of …

Hepatitis B (HBV) is a major cause of global morbidity and mortality, and the leading cause
of liver cancer worldwide. Significant advances have recently been made toward the …

Mitochondria are generally considered the powerhouse of the cell, a small subcellular
organelle that produces most of the cellular energy in the form of adenosine triphosphate …

Viral hepatitis results in 1.4 million deaths annually. The World Health Organization (WHO)
set an ambitious target to eliminate viral hepatitis by 2030, but significant challenges remain …

Abstract Purpose Circulating microRNA (miRNA) has been reported to have diagnostic
value in multiple tumors. To identify serum miRNAs for early diagnosis of hepatocellular …

Hepatocellular carcinoma (HCC) is one of the most common and deadly tumors worldwide.
Management of HCC depends on reliable biomarkers for screening, diagnosis, and …